2nd Annual Neuroscience Drug Discovery Congress

Datum: 26. - 27.05.2020
Uhrzeit: 07:30 Uhr - 17:00 Uhr

Oxford Global is proud to present our 2nd Annual Neuroscience Drug Discovery Congress, taking place 26 – 27 May 2020 in Berlin, Germany, which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Discover the latest developments and critical approaches in neuroscience discovery, alongside cutting-edge enabling tools and technologies for developing neurological treatments.

The congress encompasses the emerging trends and technological breakthroughs in drug discovery for neurodegenerative diseases, together with presentations on advancements in stem cell technologies to fuel drug discovery and iPS cells in disease modelling. On Day 2, we aim to emphasise the importance of targeted therapeutics and the crucial roles of biomarker development and gene therapy in drug discovery and translational neuroscience.

View the Agenda: https://bit.ly/2rYH2kT

With over 20 unmissable presentations, the two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

This events form part of the R&D Series EU and are co-located with our 21st Annual Drug Discovery Summit and 8th Annual Drug Design and Medicinal Chemistry Congress
For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/2PfND2z

Go Social: Join our Drug Discovery and Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and and join the conversation at #RNDSeries20

LIVE WEBINAR:
Predictive Model Approaches For Pharmacokinetics And Pharmacodynamics In CNS Discovery
Hosted by Elizabeth de Lange, Professor in Predictive Pharmacology, LACDR, Leiden University
Register (free): https://bit.ly/2RQHjBg

URL:

Brochure: https://go.evvnt.com/566274-0?pid=1368

Speakers: Emilio Merlo Pich, Executive Director Neurology and Quantitative Medicine Neuroscience Therapeutic Area, Takeda , Andreas Hartmann, Executive Director PreClinical Safety, Therapeutic Area Head, Novartis , Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier

Fachgebiete:

Innere Medizin

Veranstalter

Oxford Global
Zur Adresse

Veranstaltungsort:

Maritim Hotel Berlin
Stauffenbergstr. 26
DE 10785 Berlin
Zur Anfahrt

Buchungsinformationen

Hotels in der Nähe des Veranstaltungsortes anzeigen

Diese Veranstaltung via E-Mail weiterempfehlen

Veranstalter:

Oxford Global
Minns Business Park
GB OX2 0JB Oxford
Telefon: +44 (0)1865 248455
E-Mail: g.alonso@oxfordglobal.co.uk

Organisator:

Oxford Global
Minns Business Park
GB OX2 0JB Oxford
Telefon: +44 (0)1865 248455
E-Mail: g.alonso@oxfordglobal.co.uk

Buchung:

Onlinebuchung: https://go.evvnt.com/566274-1?pid=1368
E-Mail: g.alonso@oxfordglobal.co.uk

Bisher leider keine Daten vorhanden

Bisher leider keine Daten vorhanden

Veranstaltungsort:

Maritim Hotel Berlin
Stauffenbergstr. 26
DE 10785 Berlin


Größere Kartenansicht

Bewertung
Weitere Informationen

Turnus: keine Wiederholung

Kosten: EUR 390,00

Spezialgebiete:
Science, Health and Medicine, Pharmaceuticals, Drug Discovery

Wissenschaftliche Leitung:
Oxford Global
g.alonso@oxfordglobal.co.uk
https://go.evvnt.com/566274-2?pid=1368

HRS.de